Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D79JZU
|
|||
| Drug Name |
FT538
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60; ICD-9: 205] | Phase 1 | [1] | |
| Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 1 | [1] | ||
| Company |
Fate Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04614636) FT538 in Subjects With Advanced Hematologic Malignancies. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.